Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Clinical Journal of Oncology Nursing|October 2, 2013
Altruism--a coping mechanism for patients on clinical trials: a nursing perspectiveJudith Brown Sanders, Julie S Seda, Carl G KardinalClinical Journal of Oncology Nursing|May 30, 2012
The changing hope trajectory in patients with advanced-stage cancer: a nursing perspectiveJudith Brown Sanders, Julie S Seda, Carl G KardinalThe American Journal of the Medical Sciences|January 10, 2012
Iron deficiency anemia related to hereditary hemorrhagic telangiectasia: response to treatment with bevacizumabJessica M Fleagle, Ravi K Bobba, Carl G Kardinal, et al.Clinical Breast Cancer|January 21, 2003
Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58Roy E Smith, Stewart J Anderson, Ann Brown, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Safety and toxicity analysis of oxaliplatin combined with fluorouracil or as a single agent in patients with previously treated advanced colorectal cancerRamesh K Ramanathan, Jeffery W Clark, Nancy E Kemeny, et al.Cancer Chemotherapy and Pharmacology|June 15, 2007
A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell carcinomaWalter M Stadler, Apurva A Desai, David I Quinn, et al.Gynecologic Oncology|September 28, 2005
Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometriumHarry J Long, Robert A Nelimark, Karl C Podratz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group studyAminah Jatoi, Harold E Windschitl, Charles L Loprinzi, et al.International Journal of Gastrointestinal Cancer|June 10, 2003
A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardiaAminah Jatoi, Marisa Tria Tirona, Steven S Cha, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Randomized phase II study of two irinotecan schedules for patients with metastatic breast cancer refractory to an anthracycline, a taxane, or bothEdith A Perez, David W Hillman, James A Mailliard, et al.Pageof 2